Tavo Biotherapeutics
PrivateLast Round
Series A
Jun 2, 2026
Total Funding Raised
$29.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tavo Biotherapeutics is a biopharmaceutical company developing novel therapeutics for ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tavo Biotherapeutics Comparables
Compare Tavo Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Pharma | 88% | |
| RevOpsis Therapeutics | 82% | |
| Nicox S.A. | 72% |
Tavo Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2026 | ||||
| Grant | Sep 1, 2024 |
Key People
Founding team and executive leadership
Tavo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Tau Capital | Series A, Seed |
| NIH RADx | Grant |
| Tennessee Technology Development Corporation | Grant |
| Pureos Bioventures | Series A |
| Polaris Partners | Series A |
| National Eye Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 27% QoQ, from 11 to 14 employees.
- Jul 27, 2026
Monthly visitors increased 58% MoM.
Tavo Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tavo Biotherapeutics's valuation, stock price, and market status.
Is Tavo Biotherapeutics a public or private company?
Tavo Biotherapeutics is a private company.
What is the current stock price of Tavo Biotherapeutics?
Tavo Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tavo Biotherapeutics worth (valuation)?
Valuation information for Tavo Biotherapeutics is not publicly available.
Can I buy Tavo Biotherapeutics stock?
Tavo Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tavo Biotherapeutics's last funding round?
Tavo Biotherapeutics's most recent funding round was Series A on June 2, 2026.
Who are the main investors in Tavo Biotherapeutics?
Key investors in Tavo Biotherapeutics include Pureos Bioventures.
Will Tavo Biotherapeutics IPO soon?
No public IPO plans have been announced for Tavo Biotherapeutics.
How can I track Tavo Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tavo Biotherapeutics's secondary market activity and sign up for updates.